Land: Taiwan
Språk: kinesiska
Källa: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Siltuximab
臺灣百濟神州有限公司 臺北市信義區松仁路97號4樓 (82911456)
L04AC11
凍晶注射劑
Siltuximab (9200081300) (Nominal amount 100mg/vial)MG
玻璃小瓶裝;;盒裝
菌 疫
限由醫師使用
JANSSEN SCIENCES IRELAND UC BARNAHELY, RINGASKIDDY, CO.CORK, IRELAND IE
siltuximab
適用於治療人類免疫不全病毒(HIV)陰性及人類皰疹病毒-8(HHV-8)陰性的多發性Castleman氏病(Multicentric Castleman's Disease(MCD))患者。
有效日期: 2025/09/10; 英文品名: Sylvant® Powder for Concentrate for Solution for Infusion 400mg
2015-09-10
PLEASE NOTE: WHILST ARK PHARMA GRAPHICS WILL MAKE EVERY EFFORT TO ENSURE THE ACCURACY OF TEXT AND BARCODES ARE CAPTURED, IT IS THE ULTIMATE RESPONSIBILITY OF THE CUSTOMER’S REGULATORY DEPARTMENT AND PRODUCTION SITES TO ENSURE THAT TEXT (INCLUDING BRAILLE) AND BARCODES ARE CORRECT IN BOTH CONTENT AND ACCURACY. Cutterguide BLACK 100% 95% 50% 5% V5.04.2019 Crown House Business Centre Home Gardens, Dartford Kent DA1 1DZ Tel +44(0)1322 424656 EUSAPHARMA JOB NO.: PROOF NO.: ARTWORK APPROVAL SIGNATURE BOX PROOFREADER SITE PACKAGING REGULATORY MARKET AFFILIATE TEXT SIZES Smallest Text 7 pt Line Spacing 7.2 pt Product Name Market Component No. of Colours Profile Dimensions Barcode Pharmacode SAP Code Job No. Asset No. Packaging Supplier Originated on Originated by Originated at Amended by Date completed Reason for Update & CCR Number ARK PHARMA GRAPHICS LEA/SYL/TW/ 1216 P3/M3 Sylvant Taiwan Leaflet 2 (Two) TBC 808 x 297 mm N/A TBC N/A LEA/SYL/TW/1216/01 285 TBC 20/05/2021 Operator 001/004 ARK Operator 001/004 25/08/2021 Updates to Text Bar prints 100mm @ 100% FONTS USED Helvetica PMS 485 ® SYLVANT ® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 000984 400 000985 1 SYLVANT ® (HIV) -8 (HHV-8) Castleman (Multicentric Castleman’s disease(MCD)) HIV HHV-8 MCD SYLVANT ® SYLVANT ® IL-6 2 2.1 3 1 SYLVANT ® 11 / 12 SYLVANT ® 3 1 SYLVANT ® ® 值 ® ® 查 ® ® 氯 烯 烯烴 烯 烯 烯 ® ® ® ® ® 䆟 氯 烯 氨酯 烯 醚 ® ® ® ® ® ® ® ® ® ® ® ® ® ® 噁 ® ® ® 䳷 ® ® ® ® ® ® ® 噁 ® ® ® ® ® ® ® ® ® ® 丘 ® ® ® ® 酐 ® ® ® 值 ® 䆋 值 值 䆋 查 查 夠 ® ® ® ® ® ® ® ® LEA/SYL/TW/1216/01 LEA/SYL/TW/1216/01 a ≥ ≥ ≥ ≥ SYLVANT ® +BSC A N=53 +BSC N=26 3-4 3-4 䗻 查 查 ≥ ® 值 15 (28%) 15 (28%) 2 (4%) 2 (4%) 2 (4%) 2 (4%) 4 (8%) 14 (26%) 5 (9%) 14 (26%) 4 (8%) 4 (8%) 2 (4%) 6 (11%) 4 (8%) 4 (8%) 4 (8%) 10 (19%) 2 (4%) 1 (2%) 0 0 0 0 0 2 (4%) 1 (2%) 2 (4%) 4 (8%) 0 0 0 1 (2%) 0 0 0 1 (2%) 1 (2%) b 3 (12%) 2 (8%) 0 0 0 0 1 (4%) 4 (15%) 1 (4%) 7 (2 Läs hela dokumentet